Table 5.
Characteristics of the investigated cohort of recipients.
| All (n = 35) | Standard (n = 28) | EVLP (n = 7) | P | |
|---|---|---|---|---|
| Age, years | 47 ± 15 | 49 ± 14 | 38 ± 15 | 0.09 |
| BMI, kg/m2 | 22 [18–25] | 23 [18–25] | 20 [17–23] | 0.28 |
| Diagnosis | ||||
| Cystic fibrosis, n (%) | 14 (40) | 10 (36) | 4 (57) | 0.20 |
| Pulmonary fibrosis, n (%) | 11 (31) | 11 (40) | 0 (0) | |
| Other, n (%) | 10 (29) | 7 (25) | 3 (43) | |
| ICU admission pretransplant, n (%) | 9 (26) | 5 (18) | 4 (57) | 0.05 |
| Urgent listing, n (%) | 9 (26) | 5 (18) | 4 (57) | 0.05 |
| ECMO bridge to transplant, n (%) | 8 (23) | 5 (18) | 3 (43) | 0.31 |
| Noninvasive ventilation (%) | 5 (14) | 4 (14) | 1 (14) | 1.00 |
| Invasive ventilation (%) | 2 (6) | 1 (4) | 1 (14) | 0.37 |
| LAS transplantation | 39 [36–58] | 39 [36–46] | 79 [40–84] | <0.05 |
| Karnofsky index | 60 [13–70] | 65 [40–70] | 20 [10–50] | <0.05 |
| Lung transplant procedure | ||||
| Single, n (%) | 15 (43) | 14 (50) | 1 (14) | 0.20 |
| Double, n (%) | 20 (57) | 14 (50) | 6 (86) | |
| Total surgical time, min | 617 ± 157 | 609 ± 169 | 647 ± 93 | 0.58 |
| Intraoperative ECMO, n (%) | 13 (37) | 8 (26) | 5 (71) | 0.07 |
| Intraoperative ECMO-VA, n (%) | 6 (17) | 4 (14) | 2 (29) | 0.58 |
Data of the entire cohort of investigated recipients (All) are presented, comparing data of Standard recipients with EVLP recipients (Student's t-test; P < 0.05). Data are presented as mean ± standard deviation or median and 25°–75° percentile in square brackets.
n, number of patients; BMI, body mass index; ICU, intensive care unit; LAS, lung allocation score; ECMO, extracorporeal membrane oxygenation; VA, venous arterial.